Table 3. Examples of the distribution of variant nonamer peptides in DENV-3.
| DENV-3 protein | Nonamer position | No. of sequences | Nonamer peptidesa | Representation of peptides | Combined % representation of variantsb | Nonamer entropyc |
| E | 14 | 479 | DFVEGLSGA | 479 (100%) | 0 | 0 |
| NS2a | 176 | 64 | LAGISLLPV | 25 (39%) | 61 | 2.4 |
| LAGVSLLPV | 11 (17%) | |||||
| LAGVSLLPL | 9 (14%) | |||||
| LAVISLLPV | 9 (14%) | |||||
| LAGISLLPL | 6 (9%) | |||||
| LAGISLFPV | 2 (3%) | |||||
| LAGISLMPV | 2 (3%) | |||||
| NS4a | 86 | 68 | SIGLICVVA | 39 (57%) | 43 | 1.5 |
| SIGLICVIA | 19 (28%) | |||||
| SIGLICVIV | 8 (13%) | |||||
| SIGLICVAA | 2 (3%) |
a
The predominant peptide is underlined
b
Variants include all the peptides at the position, except the predominant
c
Entropy value of all the peptides at the position (predominant peptide included)